From Wikipedia, the free encyclopedia
Crucell, NASDAQ: CRXL, Euronext: CRXL is a biotechnology company specializing in vaccines and antibodies. Its headquarters are located in Leiden, The Netherlands. Crucell shares are listed on the Euronext Amsterdam exchange and are part of the AMX index.
[edit] History
In 1993 Introgene was founded, which is Crucell’s predecessor. The company forms a partnership with Genzyme to collaborate on its vector technology and viral-based products. In 1999 the company founded Galapagos Genomics as a joint venture together with Tibotec. In 2000 IntroGene acquires U-Bisys to form Crucell.
In 2006, Crucell and Swiss Berna Biotech; Swedish SBL Vaccines and US-based Berna Products joined forces to become the sixth largest vaccine company worldwide, with their own clinical programs.
[edit] External links
